MIG/CXCL9 exacerbates the progression of metabolic-associated fatty liver disease by disrupting Treg/Th17 balance

Hepatic lymphocytes involved in the pathogenesis of pediatric and adult non-alcoholic fatty liver disease

(2021) Victoria Cairoli et al.   Scientific Reports

Extracellular Vesicles as Inflammatory Drivers in NAFLD

(2021) Akshatha N. Srinivas et al.   Frontiers in Immunology

Molecular control of pathogenic Th17 cells in autoimmune diseases

(2020) Bing Wu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

The role of the IL‐23/Th17 pathway in cardio‐metabolic comorbidity associated with psoriasis

(2020) A Egeberg et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Protective and Detrimental Roles of p38α MAPK in Different Stages of Nonalcoholic Fatty Liver Disease

(2020) Seonghwan Hwang et al.   HEPATOLOGY

Cytokines and transcription factors in the differentiation of CD4+ T helper cell subsets and induction of tissue inflammation and autoimmunity

(2020) Mathias Pawlak et al.   CURRENT OPINION IN IMMUNOLOGY

Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway

(2019) Yayun Liu et al.   Acta Pharmaceutica Sinica B

The pathogenicity of Th17 cells in autoimmune diseases

(2019) Keiko Yasuda et al.   Seminars in Immunopathology

Total flavonoids from Tetrastigma hemsleyanum ameliorates inflammatory stress in concanavalin A-induced autoimmune hepatitis mice by regulating Treg/Th17 immune homeostasis

(2019) Weiwei Ji et al.   INFLAMMOPHARMACOLOGY

Impaired Tip60-mediated Foxp3 acetylation attenuates regulatory T cell development in rheumatoid arthritis

(2019) Qiao Su et al.   JOURNAL OF AUTOIMMUNITY

T Regulatory Cells and Priming the Suppressive Tumor Microenvironment

(2019) Christina M. Paluskievicz et al.   Frontiers in Immunology

IL-17A-mediated ERK1/2/p65 Signaling Pathway is Associated with Cell Apoptosis after Non-alcoholic Steatohepatitis

(2018) Ya-jie Pan et al.   IUBMB LIFE

Non-alcoholic fatty liver disease – A global public health perspective

(2018) Zobair M. Younossi   JOURNAL OF HEPATOLOGY

Gut-Specific Delivery of T-Helper 17 Cells Reduces Obesity and Insulin Resistance in Mice

(2017) Chun-Pyo Hong et al.   GASTROENTEROLOGY

Pro-Inflammatory CXCR3 Impairs Mitochondrial Function in Experimental Non-Alcoholic Steatohepatitis

(2017) Jinghua Du et al.   Theranostics

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosis

(2016) Hong Xu et al.   JOURNAL OF ENDOCRINOLOGY

CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy

(2016) Xiang Zhang et al.   JOURNAL OF HEPATOLOGY

The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice

(2015) S. Rolla et al.   CLINICAL SCIENCE

CXCR3 ligands in disease and therapy

(2015) Katrien Van Raemdonck et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Adipose Tissue–Derived Stem Cells From Obese Subjects Contribute to Inflammation and Reduced Insulin Response in Adipocytes Through Differential Regulation of the Th1/Th17 Balance and Monocyte Activation

(2015) Assia Eljaafari et al.   DIABETES

Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity

(2015) M G M Wolfs et al.   Nutrition & Diabetes

Th17 cells in inflammation and autoimmunity

(2014) Ram Pyare Singh et al.   AUTOIMMUNITY REVIEWS

Roles for Chemokines in Liver Disease

(2014) Fabio Marra et al.   GASTROENTEROLOGY

3, 3′-diindolylmethane alleviates steatosis and the progression of NASH partly through shifting the imbalance of Treg/Th17 cells to Treg dominance

(2014) Yun Liu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Pathophysiology of NASH: Perspectives for a Targeted Treatment

(2013) Fabio Marra et al.   CURRENT PHARMACEUTICAL DESIGN

Enhanced high-mobility group box 1 (HMGB1) modulates regulatory T cells (Treg)/T helper 17 (Th17) balance via toll-like receptor (TLR)-4-interleukin (IL)-6 pathway in patients with chronic hepatitis B

(2013) J. Li et al.   JOURNAL OF VIRAL HEPATITIS

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease

(2011) Y. Tang et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Th17 cells: The emerging reciprocal partner of regulatory T cells in the liver

(2010) Li ZHAO et al.   Journal of Digestive Diseases

Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity - a tale of conflict and conundrum

(2010) M. Müller et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Foxp3 Inhibits RORγt-mediatedIL-17AmRNA Transcription through Direct Interaction with RORγt

(2008) Kenji Ichiyama et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function

(2008) Liang Zhou et al.   NATURE